|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003241,
umls-concept:C0017262,
umls-concept:C0086045,
umls-concept:C0162638,
umls-concept:C0185117,
umls-concept:C0205251,
umls-concept:C0205296,
umls-concept:C0225336,
umls-concept:C0332157,
umls-concept:C0333516,
umls-concept:C0376515,
umls-concept:C1135183,
umls-concept:C1332397,
umls-concept:C1545588,
umls-concept:C2911684
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-4-6
|
|
pubmed:abstractText |
Cardiac and renal allo- and xenografts can acquire a natural resistance to vascular rejection. This "accommodation" involves endothelial cell (EC) expression of "survival genes" such as Bcl family members and hemoxygenase 1. Understanding what initiates this protective process would have profound implications; our hypothesis is that low concentrations of antigraft antibodies may mediate these changes.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1-hydroxy-2-oxo-3,3-bis(2-aminoethyl...,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Heterophile,
http://linkedlifedata.com/resource/pubmed/chemical/BCL2L1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Donors,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Triazenes,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/bcl-X Protein,
http://linkedlifedata.com/resource/pubmed/chemical/omega-N-Methylarginine
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
71
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
599-605
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11292287-Animals,
pubmed-meshheading:11292287-Antibodies, Heterophile,
pubmed-meshheading:11292287-Apoptosis,
pubmed-meshheading:11292287-Cells, Cultured,
pubmed-meshheading:11292287-Endothelium, Vascular,
pubmed-meshheading:11292287-Enzyme Inhibitors,
pubmed-meshheading:11292287-Humans,
pubmed-meshheading:11292287-Immunoglobulin G,
pubmed-meshheading:11292287-Nitric Oxide,
pubmed-meshheading:11292287-Nitric Oxide Donors,
pubmed-meshheading:11292287-Osmolar Concentration,
pubmed-meshheading:11292287-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:11292287-Swine,
pubmed-meshheading:11292287-Triazenes,
pubmed-meshheading:11292287-Tumor Necrosis Factor-alpha,
pubmed-meshheading:11292287-bcl-X Protein,
pubmed-meshheading:11292287-omega-N-Methylarginine
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Nitric oxide-mediated expression of Bcl-2 and Bcl-xl and protection from tumor necrosis factor-alpha-mediated apoptosis in porcine endothelial cells after exposure to low concentrations of xenoreactive natural antibody.
|
|
pubmed:affiliation |
Department of Immunology, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
